Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer. - Wikidata - awgldk - TriplyDB

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.

http://www.wikidata.org/entity/Q37703500

about

miR‑873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1.Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1.Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer

P2860

Q50067509-0AF3C2E2-037E-4060-8CF0-A4D048FAD631 Q52652929-41D62A93-FF3D-4819-9625-2DB7ADC07068 Q57115352-137A8064-A566-45D5-9537-BF3A750128E0

P2860

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.

http://www.wikidata.org/entity/Q37703500

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.

@en

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.

@nl

type

label

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.

@en

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.

@nl

prefLabel

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.

@en

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.

@nl

P1433

Q37703500-8AAEDA56-F129-4238-8EF6-1306E111909A

P1476

Q37703500-9FB51961-BD66-4A49-A792-55D1C5709EBC

P2093

Q37703500-2E77A309-5DD4-4413-91F9-388ED0D2DB70

Q37703500-A1C3A0F1-87E4-4F52-846D-41E50EFC08C6

Q37703500-C15ED6B7-E2A6-485E-904E-47F7893A370F

Q37703500-F0464EB8-8AD4-4345-A4BA-74340F8180EB

P2860

Q37703500-069BC348-B8C9-4254-AF78-B93A877CEDEC

Q37703500-07DD84AD-C606-41BA-B655-F2C5742850C4

Q37703500-12769134-36E9-4B84-85FF-48875D35E581

Q37703500-1EB803C3-A1F6-40D7-A3D0-5D14028225A9

Q37703500-1ED304AA-B70F-4A4E-96B9-130AC5D3054B

Q37703500-3B525F57-67F1-4073-9196-5EF3DEA343AE

Q37703500-3C78AC0C-BF0F-4846-860B-075F8040AD4F

Q37703500-4F4DE97C-2487-4A84-B8CA-215680959BC8

Q37703500-55295535-3A35-4A4E-AEFE-2CD08DF037C3

Q37703500-67BBC2CF-2158-4FCB-912D-6E447921F001

P304

Q37703500-61E2113D-4D02-408D-A594-C36896522565

P31

Q37703500-A9AD46EE-AD23-4D98-BF15-57C939DC427B

P356

Q37703500-173CF719-AE48-4520-BCF2-C3C682FD493D

P407

Q37703500-7C4B8385-16A3-441D-9753-677CFC84D7D9

P433

Q37703500-8DE1165D-1849-4527-80DD-F34A54321EC0

P478

Q37703500-FA978BAF-1F47-4CFD-A3CD-511E66A8AFA8

P577

Q37703500-73F89E79-26FC-4DAD-A97B-72B1CCCF2875

P698

Q37703500-0DD0DB4E-0D30-4BA1-8FD6-206B6EF0D315

P921

Q37703500-19904656-b7a3-4426-9bbf-07ef74baa129

Q37703500-8C552545-AC3E-4B5D-92E2-B455AACADA6F

Q37703500-9D21C3FF-3893-4575-B17F-E2D386B050B2

P932

Q37703500-6A366E6E-FE54-456E-81DA-613B991FAFE4

P356

WJG.V23.I10.1780

P1433

World Journal of Gastroenterology

P1476

Clinicopathological significance of overexpression of interleukin-6 in colorectal cancer.

@en

P2093

Jun Zeng

http://www.w3.org/2001/XMLSchema#string

Shan-Shan Guo

http://www.w3.org/2001/XMLSchema#string

Shuang Liu

http://www.w3.org/2001/XMLSchema#string

Zhong-Hua Tang

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance

IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer

Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.

Involvement of NF-κB/IL-6 Pathway in the Processing of Colorectal Carcinogenesis in Colitis Mice

Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis.

Upregulation of TLRs and IL-6 as a marker in human colorectal cancer.

Scutellaria barbata D. Don inhibits growth and induces apoptosis by suppressing IL-6-inducible STAT3 pathway activation in human colorectal cancer cells.

Chemokine CXCL14 is associated with prognosis in patients with colorectal carcinoma after curative resection.

Significance of interleukin-6 (IL-6) in breast cancer (review).

Interleukin-6 and risk of colorectal cancer: results from the CLUE II cohort and a meta-analysis of prospective studies.

P304

1780-1786

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V23.I10.1780

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28348483

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

5352918

http://www.w3.org/2001/XMLSchema#string